MENU
+Compare
MEDX
ETF ticker: NASDAQ
AS OF
Sep 5, 12:53 PM (EDT)
Price
$29.27
Change
+$0.07 (+0.24%)
Net Assets
17.4M

MEDX stock forecast, quote, news & analysis

The investment seeks to provide long-term growth of capital... Show more

Category: #Health
MEDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for MEDX with price predictions
Sep 04, 2025

MEDX sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for MEDX moved above the 200-day moving average on August 08, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 13, 2025. You may want to consider a long position or call options on MEDX as a result. In of 36 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MEDX just turned positive on August 15, 2025. Looking at past instances where MEDX's MACD turned positive, the stock continued to rise in of 21 cases over the following month. The odds of a continued upward trend are .

MEDX moved above its 50-day moving average on August 12, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MEDX advanced for three days, in of 167 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 102 cases where MEDX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MEDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MEDX broke above its upper Bollinger Band on September 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB).

Industry description

The investment seeks to provide long-term growth of capital. The fund is an actively-managed exchange-traded fund (“ETF”) that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries. The fund is non-diversified.

Market Cap

The average market capitalization across the Horizon Kinetics Medical ETF ETF is 91.61B. The market cap for tickers in the group ranges from 2.42M to 665.99B. LLY holds the highest valuation in this group at 665.99B. The lowest valued company is SLRX at 2.42M.

High and low price notable news

The average weekly price growth across all stocks in the Horizon Kinetics Medical ETF ETF was 44%. For the same ETF, the average monthly price growth was 50%, and the average quarterly price growth was 184%. IONS experienced the highest price growth at 39%, while SLRX experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the Horizon Kinetics Medical ETF ETF was 2%. For the same stocks of the ETF, the average monthly volume growth was -40% and the average quarterly volume growth was -34%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 77
Price Growth Rating: 54
SMR Rating: 71
Profit Risk Rating: 78
Seasonality Score: -26 (-100 ... +100)
View a ticker or compare two or three
MEDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Listed Funds Trust490 Royal Lake DriveCape Girardeau
Phone
N/A
Web
N/A